Phase II Trial of Magrolimab and Cetuximab With Pembrolizumab or Docetaxel for Recurrent/Metastatic Head Neck Squamous Cell Carcinoma

Clinical trial NCT06046482 · TERMINATED

Trial details

NCT number: NCT06046482
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Head Neck Squamous Cell Carcinoma of Head and Neck

Start date: 2023-11-28
Primary completion: 2024-08-26
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.